SPRINTer™ Human BTK Targeted Protein Degradation Stable Cell Line Assay (K562)

Background Information:

The SPRINTer Human BTK Targeted Protein Degradation Stable Cell Line Assay (K562) utilizes the BTK Targeted Protein Degradation Cell Line to monitor endogenous BTK protein levels and allow measurement of drug-induced targeted protein degradation (TPD). Genome engineering or editing techniques, such as CRISPR/Cas9, are used to introduce a small tag into the endogenous locus of interest. This allows for the quantification of changes in BTK levels when cells are treated with therapeutic agents such as targeted protein degraders. This product leverages a sensitive chemiluminescent detection system that delivers a wide dynamic range and robust Z’ for potency, efficacy, and rank‑order profiling across small molecules.
This kit includes a stable engineered cell line (supplied as two vials of cryopreserved cells); cell line specific reagents for cell thawing, propagation, detachment, cryopreservation, and cell plating; and a 10‑plate detection kit required to run the assay. Assay plates and positive control for use in the assays can be purchased separately. For continued use of the cell line, additional quantities of cell culture and assay reagents are available for purchase separately.
Eurofins DiscoverX optimized Detection Reagents are required for optimal assay performance and must be used with these cell lines in accordance with the cell line license agreed to upon purchase of this cell line assay kit.

Target Class:

Kinase

Family:

TK

Sub Family:

Protein Tyrosine

Protein Name:

BTK

Protein Aliases:

Bruton's tyrosine kinase

Accession Number:

NM_000061.3

UniProt Number:

Q06187

Gene Name:

BTK

Gene ID:

695

Gene Aliases:

ATK|XLA|PSCTK1

Target Species:

Human

Cell Background:

K562